| Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway J Polivka Jr, F Janku Pharmacology & therapeutics 142 (2), 164-175, 2014 | 969 | 2014 |
| Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation M Kropp, O Golubnitschaja, A Mazurakova, L Koklesova, N Sargheini, ... Epma Journal 14 (1), 21-42, 2023 | 441 | 2023 |
| Advances in experimental targeted therapy and immunotherapy for patients with glioblastoma multiforme J Polivka, L Holubec, T Kubikova, V Priban, O Hes, K Pivovarcikova, ... Anticancer research 37 (1), 21-33, 2017 | 175 | 2017 |
| Caution,“normal” BMI: health risks associated with potentially masked individual underweight—EPMA Position Paper 2021 O Golubnitschaja, A Liskova, L Koklesova, M Samec, K Biringer, ... EPMA Journal 12 (3), 243-264, 2021 | 154 | 2021 |
| Length of occlusion predicts recanalization and outcome after intravenous thrombolysis in middle cerebral artery stroke V Rohan, J Baxa, R Tupy, L Cerna, P Sevcik, M Friesl, J Polivka Jr, ... Stroke 45 (7), 2010-2017, 2014 | 111 | 2014 |
| “Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset?“Flammer Syndrome” relevance to address the question R Bubnov, J Polivka Jr, P Zubor, K Konieczka, O Golubnitschaja EPMA Journal 8 (2), 141-157, 2017 | 109 | 2017 |
| Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach J Polivka Jr, J Polivka, M Pesta, V Rohan, L Celedova, S Mahajani, ... EPMA Journal 10 (1), 81-99, 2019 | 89 | 2019 |
| New molecularly targeted therapies for glioblastoma multiforme J POLIVKA, V ROHAN, O TOPOLCAN, J FERDA Anticancer research 32 (7), 2935-2946, 2012 | 83 | 2012 |
| “Dry mouth” and “Flammer” syndromes—neglected risks in adolescents and new concepts by predictive, preventive and personalised approach A Kunin, J Polivka Jr, N Moiseeva, O Golubnitschaja EPMA Journal 9 (3), 307-317, 2018 | 71 | 2018 |
| The role of cetuximab in the induction of anticancer immune response in colorectal cancer treatment L Holubec, J Polivka, M Safanda, M Karas, V Liska Anticancer research 36 (9), 4421-4426, 2016 | 66 | 2016 |
| Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine J Polivka Jr, I Altun, O Golubnitschaja Epma Journal 9 (1), 1-13, 2018 | 63 | 2018 |
| Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach? P Zubor, A Gondova, J Polivka Jr, P Kasajova, K Konieczka, J Danko, ... EPMA Journal 8 (2), 129-140, 2017 | 61 | 2017 |
| Vaginal dryness: individualised patient profiles, risks and mitigating measures V Goncharenko, R Bubnov, J Polivka Jr, P Zubor, K Biringer, T Bielik, ... Epma Journal 10 (1), 73-79, 2019 | 59 | 2019 |
| Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet? J Polivka Jr, M Pesta, F Janku Expert review of molecular diagnostics 15 (12), 1631-1644, 2015 | 59 | 2015 |
| Current status of biomarker research in neurology J Polivka, J Polivka Jr, K Krakorova, M Peterka, O Topolcan EPMA journal 7 (1), 14, 2016 | 58 | 2016 |
| Isocitrate dehydrogenase‐1 mutations as prognostic biomarker in glioblastoma multiforme patients in West Bohemia J Polivka, J Polivka Jr, V Rohan, M Pesta, T Repik, P Pitule, O Topolcan BioMed research international 2014 (1), 735659, 2014 | 54 | 2014 |
| Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach O Golubnitschaja, P Potuznik, J Polivka Jr, M Pesta, O Kaverina, ... EPMA Journal 13 (4), 535-545, 2022 | 53 | 2022 |
| Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon? J Polivka Jr, M Kralickova, J Polivka, C Kaiser, W Kuhn, O Golubnitschaja EPMA Journal 8 (2), 119-127, 2017 | 50 | 2017 |
| Plasma microRNA levels combined with CEA and CA19-9 in the follow-up of colorectal cancer patients M Pesta, R Kucera, O Topolcan, M Karlikova, K Houfkova, J Polivka, ... Cancers 11 (6), 864, 2019 | 47 | 2019 |
| The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI … O Golubnitschaja, J Polivka Jr, P Potuznik, M Pesta, I Stetkarova, ... EPMA Journal 15 (1), 1-23, 2024 | 46 | 2024 |
